Clinical Cancer Research The Future of Cancer Research: Science and Patient Impact Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hwang, E. S.
Right arrow Articles by Waldman, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hwang, E. S.
Right arrow Articles by Waldman, F. M.
Clinical Cancer Research Vol. 10, 5160-5167, August 1, 2004
© 2004 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Patterns of Chromosomal Alterations in Breast Ductal Carcinoma In situ

E. Shelley Hwang1,2, Sandy DeVries2, Karen L. Chew2, Dan H. Moore, II2,8, Karla Kerlikowske3,4, Ann Thor9, Britt-Marie Ljung2,6 and Frederic M. Waldman5,6,7

Departments of 1 Surgery, 2 Cancer Center, 3 Medicine, 4 Epidemiology and Biostatistics, 5 Laboratory Medicine, 6 Pathology, and 7 Urology, University of California San Francisco, San Francisco, California; 8 California Pacific Medical Center, San Francisco, California; and 9 Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Purpose: Ductal carcinoma in situ (DCIS) is thought to be a nonobligate precursor of invasive cancer. Genomic changes specific to pure DCIS versus invasive cancer, as well as alterations unique to individual DCIS subtypes, have not been fully defined.

Experimental Design: Chromosomal copy number alterations were examined by comparative genomic hybridization in 34 cases of pure DCIS and compared with 12 cases of paired synchronous DCIS and invasive ductal cancer, as well as to 146 additional cases of invasive breast cancer of ductal or lobular histology. Genomic differences between high-grade and low/intermediate-grade DCIS, as well as between pure DCIS and invasive cancer, were identified.

Results: Pure DCIS showed almost the same degree of chromosomal instability as invasive ductal cancers. A higher proportion of low/intermediate-grade versus high-grade DCIS had loss of 16q (65 versus 12%, respectively; P = 0.002). When compared with lower grade DCIS, high-grade DCIS exhibited more frequent gain of 17q (65 versus 41%; P = 0.15) and higher frequency loss of 8p (77 versus 41%; P = 0.04). Chromosomal alterations in those cases with synchronous DCIS and invasive ductal cancer showed a high degree of shared changes within the two components.

Conclusions: DCIS is genetically advanced, showing a similar degree of chromosomal alterations as invasive ductal cancer. The pattern of alterations differed between high- and low/intermediate-grade DCIS, supporting a model in which different histological grades of DCIS are associated with distinct genomic changes. These regions of chromosomal alterations may be potential targets for treatment and/or markers of prognosis.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
V. V. Iakovlev, N. C.R. Arneson, V. Wong, C. Wang, S. Leung, G. Iakovleva, K. Warren, M. Pintilie, and S. J. Done
Genomic Differences Between Pure Ductal Carcinoma In Situ of the Breast and that Associated with Invasive Disease: a Calibrated aCGH Study
Clin. Cancer Res., July 15, 2008; 14(14): 4446 - 4454.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Vincent-Salomon, C. Lucchesi, N. Gruel, V. Raynal, G. Pierron, R. Goudefroye, F. Reyal, F. Radvanyi, R. Salmon, J.-P. Thiery, et al.
Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast
Clin. Cancer Res., April 1, 2008; 14(7): 1956 - 1965.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. C. Allred, Y. Wu, S. Mao, I. D. Nagtegaal, S. Lee, C. M. Perou, S. K. Mohsin, P. O'Connell, A. Tsimelzon, and D. Medina
Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution
Clin. Cancer Res., January 15, 2008; 14(2): 370 - 378.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. S. Hwang, D. L. Miglioretti, R. Ballard-Barbash, D. L. Weaver, K. Kerlikowske, and for the National Cancer Institute Breast Cancer Su
Association between Breast Density and Subsequent Breast Cancer Following Treatment for Ductal Carcinoma In situ
Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2587 - 2593.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. E. Ellsworth, D. L. Ellsworth, B. Love, H. L. Patney, L. R. Hoffman, J. Kane, J. A. Hooke, and C. D. Shriver
Correlation of Levels and Patterns of Genomic Instability With Histological Grading of DCIS
Ann. Surg. Oncol., November 1, 2007; 14(11): 3070 - 3077.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. S. Hwang, J. L. McLennan, D. H. Moore, B. B. Crawford, L. J. Esserman, and J. L. Ziegler
Ductal Carcinoma In Situ in BRCA Mutation Carriers
J. Clin. Oncol., February 20, 2007; 25(6): 642 - 647.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
G. Arpino, R. Laucirica, and R. M. Elledge
Premalignant and In Situ Breast Disease: Biology and Clinical Implications
Ann Intern Med, September 20, 2005; 143(6): 446 - 457.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.